Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...
A major cold storage leader caught the eye of a notable investor, who disclosed a fresh stake worth $19 million. This...
A strategic shift in how the government engages with industry is triggering a market rethink. The administration is t...
The bond market is sending a sharp signal to Washington: rising deficits and policy gridlock could raise borrowing co...
As U.S. Treasury yields climb, the tax advantages of municipal bonds are under fresh scrutiny. High-income investors ...
Quantum tech is moving from dream to data. This article explores Rigetti Computing, its revenue path, risks, and a pr...
A small AI stock makes a big move. SoundHound AI just released a pivotal update that could affect its 2027 outlook an...
While tech and AI grab headlines, other parts of the market are quietly delivering solid results. This piece explores...
As AI hype climbs, one tech stock think more could offer substantial upside in the S&P 500. This article lays out the...
A whispered cornerstone of Warren Buffett's private investing approach is said to lead the pack in a $786 million sec...
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...